Literature DB >> 23542531

Engineering skeletal muscle tissues from murine myoblast progenitor cells and application of electrical stimulation.

Daisy W J van der Schaft1, Ariane C C van Spreeuwel, Kristel J M Boonen, Marloes L P Langelaan, Carlijn V C Bouten, Frank P T Baaijens.   

Abstract

Engineered muscle tissues can be used for several different purposes, which include the production of tissues for use as a disease model in vitro, e.g. to study pressure ulcers, for regenerative medicine and as a meat alternative (1). The first reported 3D muscle constructs have been made many years ago and pioneers in the field are Vandenburgh and colleagues (2,3). Advances made in muscle tissue engineering are not only the result from the vast gain in knowledge of biochemical factors, stem cells and progenitor cells, but are in particular based on insights gained by researchers that physical factors play essential roles in the control of cell behavior and tissue development. State-of-the-art engineered muscle constructs currently consist of cell-populated hydrogel constructs. In our lab these generally consist of murine myoblast progenitor cells, isolated from murine hind limb muscles or a murine myoblast cell line C2C12, mixed with a mixture of collagen/Matrigel and plated between two anchoring points, mimicking the muscle ligaments. Other cells may be considered as well, e.g. alternative cell lines such as L6 rat myoblasts (4), neonatal muscle derived progenitor cells (5), cells derived from adult muscle tissues from other species such as human (6) or even induced pluripotent stem cells (iPS cells) (7). Cell contractility causes alignment of the cells along the long axis of the construct (8,9) and differentiation of the muscle progenitor cells after approximately one week of culture. Moreover, the application of electrical stimulation can enhance the process of differentiation to some extent (8). Because of its limited size (8 x 2 x 0.5 mm) the complete tissue can be analyzed using confocal microscopy to monitor e.g. viability, differentiation and cell alignment. Depending on the specific application the requirements for the engineered muscle tissue will vary; e.g. use for regenerative medicine requires the up scaling of tissue size and vascularization, while to serve as a meat alternative translation to other species is necessary.

Entities:  

Mesh:

Year:  2013        PMID: 23542531      PMCID: PMC3639551          DOI: 10.3791/4267

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  16 in total

1.  MicroRNA-1 and microRNA-206 improve differentiation potential of human satellite cells: a novel approach for tissue engineering of skeletal muscle.

Authors:  Merel Koning; Paul M N Werker; Daisy W J van der Schaft; Ruud A Bank; Martin C Harmsen
Journal:  Tissue Eng Part A       Date:  2011-12-20       Impact factor: 3.845

2.  Skeletal muscle satellite cells can spontaneously enter an alternative mesenchymal pathway.

Authors:  Gabi Shefer; Monika Wleklinski-Lee; Zipora Yablonka-Reuveni
Journal:  J Cell Sci       Date:  2004-10-05       Impact factor: 5.285

3.  Engineering vascularized skeletal muscle tissue.

Authors:  Shulamit Levenberg; Jeroen Rouwkema; Mara Macdonald; Evan S Garfein; Daniel S Kohane; Diane C Darland; Robert Marini; Clemens A van Blitterswijk; Richard C Mulligan; Patricia A D'Amore; Robert Langer
Journal:  Nat Biotechnol       Date:  2005-06-19       Impact factor: 54.908

4.  Stem cell function, self-renewal, and behavioral heterogeneity of cells from the adult muscle satellite cell niche.

Authors:  Charlotte A Collins; Irwin Olsen; Peter S Zammit; Louise Heslop; Aviva Petrie; Terence A Partridge; Jennifer E Morgan
Journal:  Cell       Date:  2005-07-29       Impact factor: 41.582

5.  Essential environmental cues from the satellite cell niche: optimizing proliferation and differentiation.

Authors:  K J M Boonen; K Y Rosaria-Chak; F P T Baaijens; D W J van der Schaft; M J Post
Journal:  Am J Physiol Cell Physiol       Date:  2009-03-25       Impact factor: 4.249

6.  Effects of a combined mechanical stimulation protocol: Value for skeletal muscle tissue engineering.

Authors:  Kristel J M Boonen; Marloes L P Langelaan; Roderick B Polak; Daisy W J van der Schaft; Frank P T Baaijens; Mark J Post
Journal:  J Biomech       Date:  2010-02-26       Impact factor: 2.712

7.  A simplified method for tissue engineering skeletal muscle organoids in vitro.

Authors:  J Shansky; M Del Tatto; J Chromiak; H Vandenburgh
Journal:  In Vitro Cell Dev Biol Anim       Date:  1997-10       Impact factor: 2.416

8.  Tissue-engineered skeletal muscle organoids for reversible gene therapy.

Authors:  H Vandenburgh; M Del Tatto; J Shansky; J Lemaire; A Chang; F Payumo; P Lee; A Goodyear; L Raven
Journal:  Hum Gene Ther       Date:  1996-11-10       Impact factor: 5.695

9.  The influence of serum-free culture conditions on skeletal muscle differentiation in a tissue-engineered model.

Authors:  Debby Gawlitta; Kristel J M Boonen; Cees W J Oomens; Frank P T Baaijens; Carlijn V C Bouten
Journal:  Tissue Eng Part A       Date:  2008-01       Impact factor: 3.845

10.  Primary mouse myoblast purification, characterization, and transplantation for cell-mediated gene therapy.

Authors:  T A Rando; H M Blau
Journal:  J Cell Biol       Date:  1994-06       Impact factor: 10.539

View more
  16 in total

1.  Engineering fibrin-based tissue constructs from myofibroblasts and application of constraints and strain to induce cell and collagen reorganization.

Authors:  Nicky de Jonge; Frank P T Baaijens; Carlijn V C Bouten
Journal:  J Vis Exp       Date:  2013-10-28       Impact factor: 1.355

Review 2.  Endometrial mesenchymal stem cells as a cell based therapy for pelvic organ prolapse.

Authors:  Stuart J Emmerson; Caroline E Gargett
Journal:  World J Stem Cells       Date:  2016-05-26       Impact factor: 5.326

Review 3.  Muscular dystrophy in a dish: engineered human skeletal muscle mimetics for disease modeling and drug discovery.

Authors:  Alec S T Smith; Jennifer Davis; Gabsang Lee; David L Mack; Deok-Ho Kim
Journal:  Drug Discov Today       Date:  2016-04-22       Impact factor: 7.851

4.  Differentiation and sarcomere formation in skeletal myocytes directly prepared from human induced pluripotent stem cells using a sphere-based culture.

Authors:  Saowanee Jiwlawat; Eileen Lynch; Jennifer Glaser; Ivy Smit-Oistad; Jeremy Jeffrey; Jonathan M Van Dyke; Masatoshi Suzuki
Journal:  Differentiation       Date:  2017-08-01       Impact factor: 3.880

5.  A multiplexed chip-based assay system for investigating the functional development of human skeletal myotubes in vitro.

Authors:  A S T Smith; C J Long; K Pirozzi; S Najjar; C McAleer; H H Vandenburgh; J J Hickman
Journal:  J Biotechnol       Date:  2014-06-05       Impact factor: 3.307

6.  Skeletal Muscle Regenerative Engineering.

Authors:  Xiaoyan Tang; Leila Daneshmandi; Guleid Awale; Lakshmi S Nair; Cato T Laurencin
Journal:  Regen Eng Transl Med       Date:  2019-04-02

Review 7.  Design, evaluation, and application of engineered skeletal muscle.

Authors:  Mark Juhas; Jean Ye; Nenad Bursac
Journal:  Methods       Date:  2015-10-06       Impact factor: 3.608

Review 8.  Human muscle production in vitro from pluripotent stem cells: Basic and clinical applications.

Authors:  Lu Yan; Alejandra Rodríguez-delaRosa; Olivier Pourquié
Journal:  Semin Cell Dev Biol       Date:  2021-04-30       Impact factor: 7.727

Review 9.  Creating stem cell-derived neuromuscular junctions in vitro.

Authors:  Shawn M Luttrell; Alec S T Smith; David L Mack
Journal:  Muscle Nerve       Date:  2021-07-30       Impact factor: 3.852

10.  Breaking sarcomeres by in vitro exercise.

Authors:  Zacharias Orfanos; Markus P O Gödderz; Ekaterina Soroka; Tobias Gödderz; Anastasia Rumyantseva; Peter F M van der Ven; Thomas J Hawke; Dieter O Fürst
Journal:  Sci Rep       Date:  2016-01-25       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.